[go: up one dir, main page]

PT2467136E - Formulações de 4-metilpirazol - Google Patents

Formulações de 4-metilpirazol Download PDF

Info

Publication number
PT2467136E
PT2467136E PT108364720T PT10836472T PT2467136E PT 2467136 E PT2467136 E PT 2467136E PT 108364720 T PT108364720 T PT 108364720T PT 10836472 T PT10836472 T PT 10836472T PT 2467136 E PT2467136 E PT 2467136E
Authority
PT
Portugal
Prior art keywords
methylpyrazole
formulations
Prior art date
Application number
PT108364720T
Other languages
English (en)
Inventor
Thomas E Daley
Kathy Powell
Olga Jarzebinski
Original Assignee
Raptor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raptor Therapeutics Inc filed Critical Raptor Therapeutics Inc
Publication of PT2467136E publication Critical patent/PT2467136E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT108364720T 2009-12-07 2010-12-06 Formulações de 4-metilpirazol PT2467136E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26738909P 2009-12-07 2009-12-07

Publications (1)

Publication Number Publication Date
PT2467136E true PT2467136E (pt) 2014-08-26

Family

ID=44145870

Family Applications (2)

Application Number Title Priority Date Filing Date
PT141501387T PT2774612T (pt) 2009-12-07 2010-12-06 Formulações de 4-metilpirazol
PT108364720T PT2467136E (pt) 2009-12-07 2010-12-06 Formulações de 4-metilpirazol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT141501387T PT2774612T (pt) 2009-12-07 2010-12-06 Formulações de 4-metilpirazol

Country Status (14)

Country Link
US (2) US9173850B2 (pt)
EP (3) EP3300732A1 (pt)
JP (1) JP5678088B2 (pt)
KR (1) KR101464053B1 (pt)
CN (1) CN102630162B (pt)
AU (1) AU2010328375B2 (pt)
DK (2) DK2774612T3 (pt)
ES (2) ES2646201T3 (pt)
HK (1) HK1201759A1 (pt)
PH (1) PH12012500772A1 (pt)
PT (2) PT2774612T (pt)
SG (2) SG10201710156RA (pt)
TW (1) TWI490209B (pt)
WO (1) WO2011071805A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5800669B2 (ja) 2011-10-18 2015-10-28 大阪化成株式会社 抗菌・抗カビ性付与剤、繊維類加工剤及び抗菌・抗カビ性繊維類の製造方法
EP3323412A1 (en) 2016-11-17 2018-05-23 Amalicon Holding AG Formulation comprising 4-methylpyrazole
KR102150040B1 (ko) * 2018-10-16 2020-08-31 한국과학기술원 4-메틸피라졸을 포함하는 간암 예방 또는 치료용 조성물
CN109452286B (zh) * 2018-11-12 2020-11-06 青岛大学 甲吡唑在杀灭松材线虫中的应用
CN109381458B (zh) * 2018-12-16 2020-09-01 李志武 甲吡唑及其盐在制备抗癫痫药物中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
US6120806A (en) 1997-06-25 2000-09-19 Whitmire; David R. Oral formulations for controlled release of alcohol deterrents
FR2807645B1 (fr) * 2000-04-12 2005-06-03 Oreal Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
ITBO20020284A1 (it) 2002-05-14 2003-11-14 Ima Spa Macchina opercolatrice
EP1547570B1 (en) 2002-07-05 2013-05-22 Qualicaps Co., Ltd. Capsule-filling and -sealing apparatus
PT1663216E (pt) * 2003-08-29 2012-02-14 Veloxis Pharmaceuticals As Dispersões sólidas que compreendem tacrolímus
AU2004268661A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
TW200534852A (en) * 2004-03-03 2005-11-01 Convivia 4-methylpyrazole formulations for inhibiting ethanol intolerance

Also Published As

Publication number Publication date
KR101464053B1 (ko) 2014-11-20
SG181566A1 (en) 2012-07-30
KR20120115483A (ko) 2012-10-18
US20120244217A1 (en) 2012-09-27
EP2774612A1 (en) 2014-09-10
US20160151332A1 (en) 2016-06-02
EP2467136A4 (en) 2013-01-16
JP5678088B2 (ja) 2015-02-25
TW201127816A (en) 2011-08-16
US9173850B2 (en) 2015-11-03
EP2467136A1 (en) 2012-06-27
AU2010328375B2 (en) 2015-08-27
ES2646201T3 (es) 2017-12-12
CN102630162B (zh) 2014-07-09
EP2774612B1 (en) 2017-08-30
TWI490209B (zh) 2015-07-01
AU2010328375A1 (en) 2012-04-05
EP2467136B1 (en) 2014-05-07
JP2013512930A (ja) 2013-04-18
SG10201710156RA (en) 2018-01-30
DK2774612T3 (da) 2017-11-20
WO2011071805A1 (en) 2011-06-16
EP3300732A1 (en) 2018-04-04
DK2467136T3 (da) 2014-08-11
ES2487634T3 (es) 2014-08-22
HK1201759A1 (en) 2015-09-11
PH12012500772A1 (en) 2019-03-25
CN102630162A (zh) 2012-08-08
PT2774612T (pt) 2017-11-17

Similar Documents

Publication Publication Date Title
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
EP2419392A4 (en) perfluorocarbon emulsions
ZA201204459B (en) Formulations of antibody
EP2641343A4 (en) CONFIGURATION OF A BUILDING
EP2418213A4 (en) NEURO MEDIN-U DERIVATIVE
EP2504020A4 (en) Daptomycin FORMULATIONS
BR112013013695A2 (pt) derivado de pirazol
BRPI1009465A2 (pt) Formulação
BRPI1008744A2 (pt) hidrotratamento de caboidratos
IL215864B (en) Metaxalone formulation
BR112012016923A2 (pt) Derivados de pirazol
SMT201600031B (it) Composti eterociclici di fenossimetile
BRPI1014688A2 (pt) aplicações terapêuticas de derivados de quinazolinadiona
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
IT1398296B1 (it) Disposizione di sensori
DK2453858T3 (da) Fremgangsmåde
SMT202100150T1 (it) Formulazioni migliorate
CU23884B1 (es) Derivados de dibenzotiazepina
HK1201759A1 (en) 4-methylpyrazole formulations 4-
BRPI1013462A2 (pt) Formulações herbicidas
DK2279652T3 (da) Kultivator
DK2407155T3 (da) Formuleringer af inecalcitol
BR112012000079A2 (pt) derivados fluorados de 3-hidroxipiridin-4-onas